


Healthcare Industry News: HIV/AIDS
News Release - August 21, 2020
Cipla and Stempeutics collaborate for launch of Stempeucel(R), first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI)
Source: Cipla
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
